235 related articles for article (PubMed ID: 31218970)
21. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
[TBL] [Abstract][Full Text] [Related]
22. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
[TBL] [Abstract][Full Text] [Related]
23. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
Yu AF; Raikhelkar J; Zabor EC; Tonorezos ES; Moskowitz CS; Adsuar R; Mara E; Huie K; Oeffinger KC; Steingart RM; Liu JE
Biomed Res Int; 2016; 2016():9363951. PubMed ID: 26942202
[TBL] [Abstract][Full Text] [Related]
24. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
26. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
[TBL] [Abstract][Full Text] [Related]
27. Subclinical reduction in left ventricular function using triplane and 2D speckle tracking echocardiography after anthracycline exposure in children.
Çilsal E; Oğuz AD; Tunaoğlu FS; Kula S; Pektaş A
Anatol J Cardiol; 2018 Jan; 19(1):58-66. PubMed ID: 29339701
[TBL] [Abstract][Full Text] [Related]
28. Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy.
Sofia R; Melita V; De Vita A; Ruggiero A; Romano A; Attinà G; Birritella L; Lamendola P; Lombardo A; Lanza GA; Delogu AB
Front Oncol; 2021; 11():624057. PubMed ID: 34055601
[TBL] [Abstract][Full Text] [Related]
29. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
[TBL] [Abstract][Full Text] [Related]
30. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
31. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
32. Assessment of anthracycline-induced cardiotoxicity in childhood cancer survivors during long-term follow-up using strain analysis and intraventricular pressure gradient measurements.
Hosono Y; Takahashi K; Shigemitsu S; Akimoto S; Ifuku M; Yazaki K; Wakatsuki H; Yaguchi A; Tomita O; Fujimura J; Saito M; Yoneoka D; Shimizu T
Heart Vessels; 2024 Feb; 39(2):105-116. PubMed ID: 37973710
[TBL] [Abstract][Full Text] [Related]
33. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of Echocardiographic Techniques to Detect Subclinical Cancer Therapeutics-Related Cardiac Dysfunction among High-Dose Patients When Compared with Cardiac Magnetic Resonance Imaging.
Toro-Salazar OH; Ferranti J; Lorenzoni R; Walling S; Mazur W; Raman SV; Davey BT; Gillan E; O'Loughlin M; Klas B; Hor KN
J Am Soc Echocardiogr; 2016 Feb; 29(2):119-31. PubMed ID: 26678319
[TBL] [Abstract][Full Text] [Related]
35. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
Front Pediatr; 2020; 8():123. PubMed ID: 32296665
[No Abstract] [Full Text] [Related]
36. Assessing the left atrium of childhood cancer survivors.
Loar RW; Colquitt JL; Rainusso NC; Gramatges MM; Liu AM; Noel CV; Tunuguntla HP; Lilje C; Pignatelli RH
Int J Cardiovasc Imaging; 2021 Jan; 37(1):155-162. PubMed ID: 32803485
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
38. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
[TBL] [Abstract][Full Text] [Related]
39. Impact of persistent left ventricular regional wall motion abnormalities in childhood cancer survivors after anthracycline therapy: Assessment of global left ventricular myocardial performance by 3D speckle-tracking echocardiography.
Okuma H; Noto N; Tanikawa S; Kanezawa K; Hirai M; Shimozawa K; Yagasaki H; Shichino H; Takahashi S
J Cardiol; 2017 Oct; 70(4):396-401. PubMed ID: 28238564
[TBL] [Abstract][Full Text] [Related]
40. Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country.
Zhang W; Azibani F; Okello E; Kayima J; Walusansa V; Orem J; Sliwa K
Afr Health Sci; 2021 Jun; 21(2):647-654. PubMed ID: 34795719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
